Published in Am J Respir Crit Care Med on June 07, 2007
Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest (2010) 2.51
Idiopathic pulmonary fibrosis. Orphanet J Rare Dis (2008) 2.34
Autoimmune-featured interstitial lung disease: a distinct entity. Chest (2011) 2.20
Thyroid Disease Is Prevalent and Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis. Chest (2015) 2.02
Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. Chest (2009) 1.56
Human ITCH E3 ubiquitin ligase deficiency causes syndromic multisystem autoimmune disease. Am J Hum Genet (2010) 1.43
Serum B cell-activating factor (BAFF) level in connective tissue disease associated interstitial lung disease. BMC Pulm Med (2015) 1.40
Diagnosis and treatment of connective tissue disease-associated interstitial lung disease. Chest (2013) 1.24
Identification of an autoantigen demonstrates a link between interstitial lung disease and a defect in central tolerance. Sci Transl Med (2009) 1.15
Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function. Lung (2010) 1.11
Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management. Arthritis Res Ther (2010) 1.02
Increased incidence of autoimmune markers in patients with combined pulmonary fibrosis and emphysema. BMC Pulm Med (2013) 0.96
Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis. Respir Med (2012) 0.94
The many faces of scleroderma sine scleroderma: a literature review focusing on cardiopulmonary complications. Rheumatol Int (2009) 0.90
Challenges in pulmonary fibrosis x 5: the NSIP/UIP debate. Thorax (2007) 0.85
Interstitial lung disease in connective tissue disease--mechanisms and management. Nat Rev Rheumatol (2014) 0.83
Interstitial lung diseases in Saudi Arabia: A single-center study. Ann Thorac Med (2013) 0.83
Minor salivary gland biopsy to detect primary Sjogren syndrome in patients with interstitial lung disease. Chest (2009) 0.83
Predictors of diagnosis and survival in idiopathic pulmonary fibrosis and connective tissue disease-related usual interstitial pneumonia. Respir Res (2014) 0.82
High-resolution computed tomography to differentiate chronic diffuse interstitial lung diseases with predominant ground-glass pattern using logical analysis of data. Eur Radiol (2009) 0.82
Interpretation of autoantibody positivity in interstitial lung disease and lung-dominant connective tissue disease. J Bras Pneumol (2014) 0.82
Vitamin D deficiency and reduced lung function in connective tissue-associated interstitial lung diseases. Chest (2010) 0.81
Lung-dominant connective tissue disease among patients with interstitial lung disease: prevalence, functional stability, and common extrathoracic features. J Bras Pneumol (2015) 0.80
Undifferentiated connective tissue disease presenting with prevalent interstitial lung disease: case report and review of literature. Diagn Pathol (2011) 0.80
Characterisation of patients with interstitial pneumonia with autoimmune features. Eur Respir J (2016) 0.80
Relationship between Metabolic Syndrome and Rheumatoid Arthritis. Korean J Fam Med (2016) 0.78
Clinical Implication of Proteinase-3-antineutrophil Cytoplasmic Antibody in Patients with Idiopathic Interstitial Pneumonias. Lung (2016) 0.77
Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic Sclerosis. PLoS One (2016) 0.77
Benefit of adjunctive tacrolimus in connective tissue disease-interstitial lung disease. Pulm Pharmacol Ther (2016) 0.77
Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy. BMC Pulm Med (2016) 0.77
Usual interstitial pneumonia preceding collagen vascular disease: a retrospective case control study of patients initially diagnosed with idiopathic pulmonary fibrosis. PLoS One (2014) 0.77
Interstitial lung disease in suggestive forms of connective tissue disease. J Bras Pneumol (2014) 0.76
Treatment response and long term follow-up results of nonspecific interstitial pneumonia. J Korean Med Sci (2012) 0.76
Clinical characteristics and survival in idiopathic pulmonary fibrosis and connective tissue disease-associated usual interstitial pneumonia. J Thorac Dis (2015) 0.75
Interstitial Lung Disease of the UIP Variant as the Only Presenting Symptom of Rheumatoid Arthritis. Case Rep Pulmonol (2015) 0.75
Nonspecific interstitial pneumonia: clinical associations and outcomes. BMC Pulm Med (2014) 0.75
Influence of autoimmune biomarkers on interstitial lung diseases: A tertiary referral center based case-control study. Respir Med (2015) 0.75
Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations. Clin Med Insights Circ Respir Pulm Med (2016) 0.75
Classification of idiopathic interstitial pneumonias using anti-myxovirus resistance-protein 1 autoantibody. Sci Rep (2017) 0.75
Rheumatoid arthritis-associated autoantibodies and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis. Thorax (2016) 0.75
Nonspecific Interstitial pneumonia (NSIP)/ Overlap or Distinct Entity: A case report from the National Research Institute of Tuberculosis and Lung Disease (NRITLD). Caspian J Intern Med (2014) 0.75
Idiopathic nonspecific interstitial pneumonia: an unrecognized autoimmune disease? Am J Respir Crit Care Med (2007) 0.75
Significance of myositis autoantibody in patients with idiopathic interstitial lung disease. Yonsei Med J (2015) 0.75
Advantages of Extracellular Ubiquitin in Modulation of Immune Responses. Mediators Inflamm (2016) 0.75
Lung involvement in "stable" undifferentiated connective tissue diseases: a rheumatology perspective. Clin Rheumatol (2017) 0.75
Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF). J Clin Med (2017) 0.75
[Interstitial lung diseases]. Pathologe (2008) 0.75
Interstitial Pneumonia With Autoimmune Features: Value of Histopathology. Arch Pathol Lab Med (2017) 0.75
Interstitial pneumonia with autoimmune features: an additional risk factor for ARDS? Ann Intensive Care (2017) 0.75
[Interstitial lung disease]. Z Rheumatol (2009) 0.75
Autoimmune pancreatitis. N Engl J Med (2006) 5.00
Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (1998) 4.88
Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol (2006) 4.70
Autoimmune hepatitis. N Engl J Med (2006) 4.15
Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med (2008) 3.97
Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med (2002) 3.06
Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum (2002) 2.99
The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med (2000) 2.63
Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol (1994) 2.37
Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J (1998) 2.23
A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med (1999) 2.08
Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics (2000) 2.06
Diagnostic criteria for autoimmune chronic pancreatitis revisited. World J Gastroenterol (2006) 1.82
Undifferentiated connective tissue diseases: the clinical and serological profiles of 91 patients followed for at least 1 year. Lupus (1998) 1.79
Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med (2001) 1.78
High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis. J Rheumatol (2006) 1.68
Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol (1999) 1.68
Antibodies in some chronic fibrosing lung diseases. II. Immunofluorescent studies. Clin Allergy (1971) 1.47
Circulating immune complexes in patients with cryptogenic fibrosing alveolitis. Clin Exp Immunol (1979) 1.44
Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clin Exp Rheumatol (2003) 1.27
Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med (2004) 1.27
Chronic hypersensitivity pneumonitis. Am J Surg Pathol (2006) 1.17
Defining unclassifiable connective tissue diseases: incomplete, undifferentiated, or both? J Rheumatol (2005) 1.16
Routine quantification of rheumatoid factor by rate nephelometry. Ann Rheum Dis (1985) 1.15
Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD. Clin Rheumatol (1998) 1.13
Undifferentiated connective tissue diseases (UCTD). Autoimmun Rev (2006) 1.04
Idiopathic non-specific interstitial pneumonia: as an "autoimmune interstitial pneumonia". Respir Med (2005) 1.04
Evaluative laboratory testing practices of United States rheumatologists. Arthritis Rheum (1998) 1.03
Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD. J Rheumatol (1999) 0.97
High-resolution CT findings of lung disease in patients with polymyositis and dermatomyositis. J Thorac Imaging (1996) 0.95
Early undifferentiated connective tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases. J Rheumatol (1991) 0.89
Nonspecific interstitial pneumonia: a real clinical entity? Clin Chest Med (2004) 0.89
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med (2011) 22.39
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med (2014) 10.62
Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci U S A (2006) 7.08
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med (2013) 6.82
Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2007) 6.71
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med (2012) 6.51
American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken) (2012) 6.51
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. Am J Respir Crit Care Med (2015) 6.03
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med (2004) 6.02
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet (2011) 5.94
Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials. Am J Respir Crit Care Med (2012) 5.33
Clinical decisions. American Board of Internal Medicine maintenance of certification program. N Engl J Med (2010) 4.85
The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med (2005) 4.25
A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N Engl J Med (2010) 4.19
Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med (2005) 4.03
Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med (2008) 3.97
Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med (2009) 3.97
Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2003) 3.89
Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2010) 3.37
Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J Clin Invest (2008) 3.29
A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies. Lancet (2012) 3.20
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet (2013) 3.17
Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med (2004) 2.97
6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis. Eur Respir J (2013) 2.92
Subglottic secretion drainage for preventing ventilator-associated pneumonia: a meta-analysis. Am J Med (2005) 2.67
Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference. Am J Respir Crit Care Med (2011) 2.62
Prevalence and prognosis of unclassifiable interstitial lung disease. Eur Respir J (2012) 2.57
Distinct pathways of genomic progression to benign and malignant tumors of the liver. Proc Natl Acad Sci U S A (2007) 2.56
Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat Med (2007) 2.54
Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2011) 2.54
A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med (2012) 2.54
Low tidal volume reduces epithelial and endothelial injury in acid-injured rat lungs. Am J Respir Crit Care Med (2002) 2.40
Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc (2006) 2.40
Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. Am J Respir Crit Care Med (2010) 2.40
Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2011) 2.32
The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Respir Med (2009) 2.18
Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest (2003) 2.16
Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol (2010) 2.03
Clinical problem-solving. Anchors away. N Engl J Med (2007) 2.02
Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. J Clin Invest (2007) 2.00
Viral infection in acute exacerbation of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2011) 2.00
Calcium-activated chloride channel TMEM16A modulates mucin secretion and airway smooth muscle contraction. Proc Natl Acad Sci U S A (2012) 1.97
Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am J Respir Crit Care Med (2007) 1.94
High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med (2005) 1.90
Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern. PLoS One (2007) 1.88
Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med (2014) 1.80
Hypersensitivity pneumonitis: insights in diagnosis and pathobiology. Am J Respir Crit Care Med (2012) 1.79
Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med (2002) 1.76
Mast cell dipeptidyl peptidase I mediates survival from sepsis. J Clin Invest (2004) 1.75
Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J Immunol (2006) 1.75
Clinical problem-solving. Why "why" matters. N Engl J Med (2004) 1.72
Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy. Radiology (2004) 1.69
Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology (2002) 1.68
BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease. Sci Transl Med (2013) 1.67
Nosocomial pneumonia: state of the science. Am J Infect Control (2006) 1.65
Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response. Chest (2008) 1.64
Idiopathic interstitial pneumonias: CT features. Radiology (2005) 1.61
A practical guide for clinicians who treat patients with amiodarone: 2007. Heart Rhythm (2007) 1.61
Protease-activated receptor 2, dipeptidyl peptidase I, and proteases mediate Clostridium difficile toxin A enteritis. Gastroenterology (2007) 1.60
Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. Radiology (2004) 1.58
Predictors of mortality in rheumatoid arthritis-related interstitial lung disease. Respirology (2013) 1.57
Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. Chest (2009) 1.56
Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. Am J Respir Crit Care Med (2014) 1.54
Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure. Eur Respir J (2013) 1.54
Respiratory bronchiolitis-interstitial lung disease: long-term outcome. Chest (2007) 1.53
Risk prediction in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2012) 1.52
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial. Ann Intern Med (2013) 1.51
Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev Pathol (2013) 1.51
Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. Chest (2009) 1.50
Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing. J Immunol (2008) 1.48
The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference. Thorax (2009) 1.46
An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus. Arthritis Rheum (2008) 1.44
Current perspectives on the treatment of idiopathic pulmonary fibrosis. Proc Am Thorac Soc (2006) 1.44
Open-access biorepository for idiopathic pulmonary fibrosis. The way forward. Ann Am Thorac Soc (2014) 1.42
Clinical problem-solving. A perfect storm. N Engl J Med (2005) 1.41
Clinical problem-solving. Diagnosis still in question. N Engl J Med (2002) 1.38
Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease. Respir Med (2007) 1.37